Trump's Drug Price Deal: Lower Costs, New Platform

President Trump announces major pharmaceutical companies will lower prescription drug prices in the U.S., matching prices in other developed countries for Medicaid patients. This includes new medications at a most-favored-nation price. The move aims to address high drug costs, impacting those without coverage or high out-of-pocket expenses. Medicaid patients may see reduced co-payments, benefiting state budgets. A new platform, TrumpRx, will launch in January for direct drug purchases. Companies will also donate supplies to a national reserve, ensuring availability of critical medications during emergencies. DNN | The Daily News Now! The world’s first global local news network. Every city. Every story. AI powered. Hosted on Acast. See acast.com/privacy for more information.